|
|
| 2.44 Delayed Data As of Mar 05 |  +0.03 / +1.24%Today’s Change | 1.55 Today|||52-Week Range 5.04 | +23.23% Year-to-Date |
| Other institutional | 0.83% |
| Mutual fund holders | 0.27% |
| Individual stakeholders | -- |
| 12/31/2014 | TOWER RESEARCH CAPITAL LLC Sold 123.00 shares of X T L Biopharmaceuticals ... |
| 12/31/2014 | COLUMBIA MANAGEMENT INVESTMENT A... Sold 441.00 shares of X T L Biopharmaceuticals ... |
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Invesco Asset Management Ltd. | 1.09% | 129,811 | 259,622 | 0 | 0.00% |
| Tower Research Capital LLC | 0.01% | 1,026 | 2,052 | -123 | -10.70% |
| UBS Securities LLC | 0.00% | 0 | 0 | -1,264 | -100.00% |
| Columbia Management Investment Ad... | 0.00% | 0 | 0 | -441 | -100.00% |
| Morgan Stanley & Co. LLC | 0.00% | 4 | 8 | 0 | 0.00% |
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Keystone Investment Trust Plc | 0.22% | 25,748 | 51,496 | -92 | -0.36% |
| Invesco Perpetual UK 2 Invt. Seri... | 0.05% | 5,958 | 11,916 | 0 | 0.00% |
